Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 53 | 2024 | 10256 | 3.210 |
Why?
|
Clonal Anergy | 24 | 2008 | 169 | 2.950 |
Why?
|
Cord Blood Stem Cell Transplantation | 9 | 2019 | 316 | 2.750 |
Why?
|
rap1 GTP-Binding Proteins | 10 | 2013 | 51 | 1.750 |
Why?
|
Neoplasms | 18 | 2024 | 22340 | 1.320 |
Why?
|
Graft vs Host Disease | 15 | 2019 | 3079 | 1.290 |
Why?
|
Adaptor Proteins, Signal Transducing | 12 | 2021 | 2897 | 1.220 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 12 | 2012 | 314 | 1.220 |
Why?
|
Lymphocyte Activation | 39 | 2024 | 5500 | 1.190 |
Why?
|
Interleukin-7 | 7 | 2015 | 146 | 1.180 |
Why?
|
Virus Activation | 3 | 2019 | 322 | 1.180 |
Why?
|
Tumor Microenvironment | 9 | 2024 | 3940 | 1.150 |
Why?
|
CD4-Positive T-Lymphocytes | 13 | 2015 | 4405 | 1.080 |
Why?
|
T-Lymphocytes, Helper-Inducer | 7 | 2018 | 975 | 1.060 |
Why?
|
T-Lymphocytes, Regulatory | 10 | 2024 | 3111 | 1.060 |
Why?
|
Fetal Blood | 6 | 2019 | 1365 | 1.000 |
Why?
|
Immunotherapy | 11 | 2023 | 4746 | 0.970 |
Why?
|
T-Lymphocyte Subsets | 8 | 2019 | 1812 | 0.900 |
Why?
|
Myelopoiesis | 1 | 2024 | 135 | 0.870 |
Why?
|
Tumor Suppressor Proteins | 12 | 2009 | 2795 | 0.830 |
Why?
|
PTEN Phosphohydrolase | 2 | 2022 | 1117 | 0.820 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2023 | 890 | 0.810 |
Why?
|
Interleukin-17 | 3 | 2013 | 921 | 0.770 |
Why?
|
Signal Transduction | 41 | 2022 | 23597 | 0.760 |
Why?
|
Interleukin-2 | 21 | 2012 | 1894 | 0.740 |
Why?
|
BK Virus | 2 | 2019 | 120 | 0.720 |
Why?
|
Membrane Proteins | 14 | 2021 | 7847 | 0.700 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 1 | 2020 | 61 | 0.690 |
Why?
|
Integrins | 5 | 2021 | 838 | 0.690 |
Why?
|
Myeloid Cells | 3 | 2022 | 838 | 0.680 |
Why?
|
Polyomavirus Infections | 2 | 2019 | 193 | 0.660 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2020 | 225 | 0.630 |
Why?
|
Jurkat Cells | 12 | 2020 | 738 | 0.630 |
Why?
|
Tumor Virus Infections | 2 | 2019 | 438 | 0.620 |
Why?
|
Thymus Gland | 3 | 2014 | 1259 | 0.620 |
Why?
|
Peyer's Patches | 1 | 2018 | 120 | 0.610 |
Why?
|
Hematopoietic Stem Cell Transplantation | 10 | 2019 | 5752 | 0.590 |
Why?
|
Cyclin-Dependent Kinase 2 | 4 | 2014 | 185 | 0.590 |
Why?
|
Herpesvirus 6, Human | 1 | 2018 | 97 | 0.580 |
Why?
|
Antigens, CD | 28 | 2019 | 4023 | 0.580 |
Why?
|
Immune Tolerance | 12 | 2014 | 2324 | 0.570 |
Why?
|
Antigens, Differentiation | 14 | 2010 | 919 | 0.550 |
Why?
|
Killer Cells, Natural | 2 | 2024 | 2206 | 0.550 |
Why?
|
Smad3 Protein | 4 | 2012 | 165 | 0.540 |
Why?
|
Immunologic Memory | 2 | 2024 | 1374 | 0.530 |
Why?
|
cdc25 Phosphatases | 2 | 2012 | 60 | 0.510 |
Why?
|
Immunity | 2 | 2020 | 1000 | 0.510 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 4 | 2005 | 166 | 0.500 |
Why?
|
Phosphorylation | 16 | 2020 | 8279 | 0.500 |
Why?
|
Receptors, Antigen, T-Cell | 17 | 2016 | 2570 | 0.500 |
Why?
|
CD8-Positive T-Lymphocytes | 7 | 2024 | 4641 | 0.500 |
Why?
|
Flow Cytometry | 6 | 2021 | 5880 | 0.490 |
Why?
|
Hematopoietic Stem Cells | 4 | 2024 | 3405 | 0.480 |
Why?
|
Animals | 66 | 2024 | 168735 | 0.480 |
Why?
|
Stem Cell Factor | 1 | 2015 | 194 | 0.480 |
Why?
|
Colonic Neoplasms | 2 | 2020 | 2530 | 0.470 |
Why?
|
Immunoconjugates | 13 | 2002 | 976 | 0.470 |
Why?
|
Angiogenesis Inducing Agents | 1 | 2016 | 254 | 0.470 |
Why?
|
ras Proteins | 4 | 2012 | 1054 | 0.470 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 3 | 2012 | 379 | 0.470 |
Why?
|
S-Phase Kinase-Associated Proteins | 3 | 2012 | 84 | 0.460 |
Why?
|
Cell Adhesion | 8 | 2021 | 3089 | 0.460 |
Why?
|
Immunity, Humoral | 1 | 2018 | 607 | 0.460 |
Why?
|
Cell Cycle | 12 | 2009 | 2920 | 0.460 |
Why?
|
Oxidation-Reduction | 2 | 2023 | 2219 | 0.460 |
Why?
|
Forkhead Transcription Factors | 5 | 2023 | 1623 | 0.450 |
Why?
|
Lipid Metabolism | 2 | 2020 | 1893 | 0.450 |
Why?
|
G1 Phase | 4 | 2012 | 403 | 0.450 |
Why?
|
Lipolysis | 1 | 2015 | 211 | 0.440 |
Why?
|
Tumor Escape | 1 | 2016 | 371 | 0.440 |
Why?
|
B-Lymphocytes | 10 | 2018 | 4782 | 0.440 |
Why?
|
Cell Cycle Proteins | 10 | 2006 | 3431 | 0.430 |
Why?
|
Cell Differentiation | 11 | 2022 | 11639 | 0.420 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 779 | 0.420 |
Why?
|
Casein Kinase II | 1 | 2013 | 120 | 0.410 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2012 | 76 | 0.410 |
Why?
|
Core Binding Factor Alpha 3 Subunit | 1 | 2012 | 58 | 0.400 |
Why?
|
Glycolysis | 2 | 2024 | 837 | 0.400 |
Why?
|
Autoimmunity | 3 | 2014 | 1354 | 0.400 |
Why?
|
Viremia | 2 | 2019 | 727 | 0.400 |
Why?
|
Cyclin-Dependent Kinases | 7 | 2006 | 659 | 0.390 |
Why?
|
Immunophenotyping | 11 | 2021 | 1865 | 0.390 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2009 | 2879 | 0.390 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2012 | 2877 | 0.370 |
Why?
|
Receptors, Interleukin-2 | 5 | 2005 | 561 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2012 | 2455 | 0.370 |
Why?
|
Humans | 136 | 2024 | 765926 | 0.370 |
Why?
|
Autoimmune Diseases | 1 | 2023 | 2248 | 0.360 |
Why?
|
Transforming Growth Factor beta | 4 | 2010 | 1996 | 0.350 |
Why?
|
Carrier Proteins | 6 | 2009 | 4909 | 0.350 |
Why?
|
Mice | 40 | 2024 | 81782 | 0.340 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 352 | 0.340 |
Why?
|
Immunity, Innate | 2 | 2021 | 3078 | 0.340 |
Why?
|
Purines | 2 | 2014 | 616 | 0.340 |
Why?
|
Melanoma | 3 | 2020 | 5695 | 0.340 |
Why?
|
Phospholipase C gamma | 1 | 2009 | 130 | 0.330 |
Why?
|
HLA-DR7 Antigen | 6 | 1996 | 27 | 0.330 |
Why?
|
Cells, Cultured | 20 | 2015 | 18962 | 0.320 |
Why?
|
Isoantigens | 6 | 2005 | 561 | 0.320 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2016 | 8603 | 0.320 |
Why?
|
Neoplasm Proteins | 3 | 2015 | 3592 | 0.310 |
Why?
|
Receptors, OX40 | 1 | 2008 | 46 | 0.300 |
Why?
|
Lymphocyte Depletion | 2 | 2008 | 606 | 0.300 |
Why?
|
Cytomegalovirus | 2 | 2010 | 753 | 0.300 |
Why?
|
Clone Cells | 10 | 2010 | 1670 | 0.300 |
Why?
|
Cell Proliferation | 10 | 2014 | 10426 | 0.300 |
Why?
|
Interleukin-1beta | 2 | 2012 | 1027 | 0.300 |
Why?
|
Adoptive Transfer | 2 | 2010 | 827 | 0.300 |
Why?
|
Proto-Oncogene Proteins | 8 | 2005 | 4520 | 0.290 |
Why?
|
Antibodies, Monoclonal | 8 | 2023 | 9239 | 0.290 |
Why?
|
Hematologic Neoplasms | 2 | 2016 | 1926 | 0.280 |
Why?
|
MAP Kinase Signaling System | 3 | 2012 | 1489 | 0.280 |
Why?
|
Enzyme Activation | 6 | 2020 | 3583 | 0.280 |
Why?
|
Fatty Acids | 1 | 2015 | 1804 | 0.280 |
Why?
|
Phagocytosis | 4 | 2024 | 1517 | 0.270 |
Why?
|
Glioma | 2 | 2022 | 3491 | 0.270 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 9 | 2008 | 1643 | 0.270 |
Why?
|
Mice, Inbred C57BL | 12 | 2024 | 22327 | 0.270 |
Why?
|
Down-Regulation | 5 | 2004 | 2925 | 0.260 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2015 | 1433 | 0.260 |
Why?
|
Granzymes | 4 | 2024 | 278 | 0.260 |
Why?
|
Cell Adhesion Molecules | 3 | 2004 | 1609 | 0.260 |
Why?
|
Transcription, Genetic | 10 | 2012 | 7599 | 0.260 |
Why?
|
COS Cells | 5 | 2020 | 1135 | 0.250 |
Why?
|
Growth Inhibitors | 1 | 2006 | 375 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinases | 7 | 2005 | 1239 | 0.240 |
Why?
|
Integrin alpha Chains | 1 | 2005 | 93 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-fyn | 3 | 2020 | 114 | 0.240 |
Why?
|
Th2 Cells | 3 | 2008 | 1074 | 0.240 |
Why?
|
Interleukin-10 | 2 | 2001 | 1181 | 0.240 |
Why?
|
Cyclic AMP | 3 | 2007 | 1466 | 0.240 |
Why?
|
Cytoskeleton | 1 | 2009 | 1178 | 0.230 |
Why?
|
Protein Multimerization | 2 | 2020 | 959 | 0.230 |
Why?
|
Interphase | 1 | 2004 | 226 | 0.230 |
Why?
|
Interferon-alpha | 5 | 1991 | 909 | 0.220 |
Why?
|
Brain Neoplasms | 3 | 2023 | 9065 | 0.220 |
Why?
|
Dendritic Cells | 8 | 2024 | 2745 | 0.220 |
Why?
|
Cytokines | 11 | 2019 | 7417 | 0.220 |
Why?
|
Contractile Proteins | 1 | 2004 | 240 | 0.220 |
Why?
|
Transplantation, Homologous | 5 | 2014 | 4859 | 0.210 |
Why?
|
Cytomegalovirus Infections | 1 | 2010 | 837 | 0.210 |
Why?
|
Epigenesis, Genetic | 1 | 2016 | 3816 | 0.210 |
Why?
|
Lung | 1 | 2021 | 10046 | 0.210 |
Why?
|
Apoptosis | 11 | 2019 | 9505 | 0.210 |
Why?
|
ADP-Ribosylation Factors | 1 | 2003 | 130 | 0.210 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2022 | 121 | 0.210 |
Why?
|
Transfection | 10 | 2007 | 5738 | 0.200 |
Why?
|
Lymphocytes | 2 | 2010 | 2601 | 0.200 |
Why?
|
Glioblastoma | 3 | 2023 | 3458 | 0.200 |
Why?
|
DNA Methylation | 1 | 2016 | 4424 | 0.200 |
Why?
|
Desensitization, Immunologic | 1 | 2008 | 545 | 0.200 |
Why?
|
Retinoblastoma Protein | 4 | 2012 | 666 | 0.200 |
Why?
|
Phosphoproteins | 4 | 2012 | 2444 | 0.190 |
Why?
|
src Homology Domains | 2 | 2020 | 361 | 0.190 |
Why?
|
Mice, Transgenic | 7 | 2020 | 9541 | 0.190 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 2021 | 22 | 0.190 |
Why?
|
Tumor Necrosis Factor-alpha | 6 | 2009 | 4342 | 0.180 |
Why?
|
Receptors, Immunologic | 2 | 2019 | 1415 | 0.180 |
Why?
|
Cell Nucleus | 2 | 2007 | 2864 | 0.180 |
Why?
|
Inflammation | 1 | 2020 | 10843 | 0.180 |
Why?
|
Gene Expression Regulation, Leukemic | 2 | 2001 | 657 | 0.170 |
Why?
|
Microfilament Proteins | 2 | 2004 | 1130 | 0.170 |
Why?
|
Remission Induction | 8 | 2016 | 2413 | 0.170 |
Why?
|
Allergens | 1 | 2008 | 1435 | 0.170 |
Why?
|
Lymphocyte Culture Test, Mixed | 8 | 2007 | 511 | 0.170 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2023 | 589 | 0.160 |
Why?
|
Brain Edema | 1 | 2023 | 601 | 0.160 |
Why?
|
Membrane Glycoproteins | 13 | 2002 | 3690 | 0.160 |
Why?
|
Protein-Tyrosine Kinases | 6 | 2003 | 2423 | 0.160 |
Why?
|
Protein Structure, Tertiary | 5 | 2013 | 3749 | 0.160 |
Why?
|
Mice, Knockout | 8 | 2024 | 14450 | 0.160 |
Why?
|
Macrophage Activation | 1 | 2002 | 552 | 0.160 |
Why?
|
Antigen Presentation | 5 | 2024 | 1250 | 0.160 |
Why?
|
Tyrosine | 2 | 2019 | 1427 | 0.150 |
Why?
|
Foscarnet | 1 | 2018 | 36 | 0.150 |
Why?
|
Cancer Vaccines | 3 | 2016 | 1042 | 0.150 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2013 | 2430 | 0.150 |
Why?
|
Hypersensitivity | 1 | 2008 | 1167 | 0.150 |
Why?
|
Reactive Oxygen Species | 2 | 2023 | 2141 | 0.150 |
Why?
|
Histocompatibility Antigens Class II | 4 | 2024 | 1440 | 0.150 |
Why?
|
Immunologic Factors | 2 | 2022 | 1590 | 0.150 |
Why?
|
Microtubule-Associated Proteins | 2 | 2000 | 1065 | 0.150 |
Why?
|
Ubiquitin | 2 | 2013 | 839 | 0.150 |
Why?
|
Antigen-Presenting Cells | 5 | 2010 | 960 | 0.140 |
Why?
|
Coculture Techniques | 3 | 2014 | 1336 | 0.140 |
Why?
|
Up-Regulation | 5 | 2012 | 4130 | 0.140 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2007 | 2838 | 0.140 |
Why?
|
Chimerism | 1 | 2018 | 154 | 0.140 |
Why?
|
Neoplastic Stem Cells | 4 | 2004 | 1351 | 0.140 |
Why?
|
Gene Expression Regulation | 8 | 2013 | 11895 | 0.140 |
Why?
|
Protein Kinase Inhibitors | 2 | 2014 | 5691 | 0.140 |
Why?
|
3T3 Cells | 7 | 1998 | 1079 | 0.140 |
Why?
|
Tuberculosis, Pulmonary | 2 | 2002 | 836 | 0.140 |
Why?
|
Cell Line, Tumor | 7 | 2024 | 17060 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 4 | 2011 | 473 | 0.140 |
Why?
|
Cell Line | 9 | 2012 | 15540 | 0.140 |
Why?
|
Disease-Free Survival | 4 | 2016 | 6838 | 0.140 |
Why?
|
Immunosuppressive Agents | 4 | 2018 | 4213 | 0.140 |
Why?
|
Interleukin-4 | 7 | 2008 | 1149 | 0.140 |
Why?
|
Hodgkin Disease | 8 | 2004 | 1383 | 0.140 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2019 | 1150 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 4 | 2011 | 478 | 0.130 |
Why?
|
Protein Kinases | 3 | 2008 | 1611 | 0.130 |
Why?
|
Angiopoietin-1 | 1 | 2016 | 132 | 0.130 |
Why?
|
Antineoplastic Agents | 3 | 2016 | 13631 | 0.130 |
Why?
|
Thrombomodulin | 1 | 2016 | 107 | 0.130 |
Why?
|
Germinal Center | 1 | 2018 | 379 | 0.130 |
Why?
|
Cyclins | 4 | 2002 | 598 | 0.130 |
Why?
|
Gangliosides | 1 | 1996 | 132 | 0.130 |
Why?
|
Antioxidants | 1 | 2023 | 1671 | 0.130 |
Why?
|
Mucin-1 | 2 | 2010 | 535 | 0.130 |
Why?
|
Angiopoietin-2 | 1 | 2016 | 186 | 0.120 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 1559 | 0.120 |
Why?
|
Skin Neoplasms | 1 | 2014 | 5836 | 0.120 |
Why?
|
Immunity, Mucosal | 1 | 2018 | 498 | 0.120 |
Why?
|
Carnitine O-Palmitoyltransferase | 1 | 2015 | 81 | 0.120 |
Why?
|
Guanine | 5 | 1996 | 281 | 0.120 |
Why?
|
Talin | 3 | 2013 | 47 | 0.120 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 3 | 2004 | 317 | 0.120 |
Why?
|
Lymphoma, Non-Hodgkin | 4 | 1999 | 1374 | 0.120 |
Why?
|
DNA, Viral | 2 | 2019 | 2196 | 0.120 |
Why?
|
Actins | 4 | 2007 | 2057 | 0.120 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2008 | 577 | 0.120 |
Why?
|
Macrophages | 4 | 2023 | 5772 | 0.120 |
Why?
|
Proteins | 3 | 2007 | 5994 | 0.120 |
Why?
|
Female | 35 | 2024 | 396141 | 0.110 |
Why?
|
Bone Marrow Transplantation | 2 | 1999 | 2729 | 0.110 |
Why?
|
Recurrence | 3 | 2016 | 8492 | 0.110 |
Why?
|
Treatment Outcome | 10 | 2020 | 65194 | 0.110 |
Why?
|
RNA Splicing | 1 | 2018 | 902 | 0.110 |
Why?
|
HLA-B7 Antigen | 1 | 1993 | 48 | 0.110 |
Why?
|
Pseudopodia | 2 | 2004 | 168 | 0.110 |
Why?
|
Interferon-gamma | 7 | 2014 | 3158 | 0.110 |
Why?
|
Recombinant Proteins | 9 | 2007 | 6491 | 0.110 |
Why?
|
Lymphopoiesis | 1 | 2014 | 132 | 0.110 |
Why?
|
Cell Separation | 2 | 2010 | 1718 | 0.110 |
Why?
|
Transcriptional Activation | 2 | 2012 | 1743 | 0.110 |
Why?
|
Ligands | 6 | 2021 | 3272 | 0.110 |
Why?
|
GTP-Binding Proteins | 1 | 1997 | 944 | 0.110 |
Why?
|
Enzyme Stability | 1 | 2013 | 218 | 0.100 |
Why?
|
Phosphatidylinositol Phosphates | 2 | 2012 | 201 | 0.100 |
Why?
|
Vaccination | 4 | 2016 | 3430 | 0.100 |
Why?
|
Receptors, Antigen, B-Cell | 3 | 2008 | 545 | 0.100 |
Why?
|
Glucose | 1 | 2004 | 4335 | 0.100 |
Why?
|
Male | 32 | 2024 | 363815 | 0.100 |
Why?
|
RNA, Messenger | 9 | 2013 | 12768 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 632 | 0.100 |
Why?
|
Molecular Structure | 1 | 2016 | 1880 | 0.100 |
Why?
|
Adult | 28 | 2019 | 223088 | 0.100 |
Why?
|
Perforin | 1 | 2012 | 166 | 0.100 |
Why?
|
Growth Substances | 1 | 1994 | 758 | 0.100 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2016 | 1167 | 0.100 |
Why?
|
Tissue Donors | 3 | 2018 | 2392 | 0.100 |
Why?
|
WT1 Proteins | 2 | 2014 | 182 | 0.100 |
Why?
|
Protein Binding | 2 | 2020 | 9296 | 0.100 |
Why?
|
Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2012 | 151 | 0.090 |
Why?
|
Genetic Predisposition to Disease | 1 | 2013 | 18074 | 0.090 |
Why?
|
Procarbazine | 4 | 2004 | 172 | 0.090 |
Why?
|
Cell Survival | 7 | 2011 | 5745 | 0.090 |
Why?
|
HEK293 Cells | 1 | 2020 | 4257 | 0.090 |
Why?
|
Phosphotyrosine | 2 | 2005 | 459 | 0.090 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 2 | 2004 | 634 | 0.090 |
Why?
|
Middle Aged | 26 | 2019 | 223016 | 0.090 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 2 | 2004 | 893 | 0.090 |
Why?
|
Gene Expression | 5 | 2012 | 7581 | 0.090 |
Why?
|
Dacarbazine | 5 | 2004 | 552 | 0.090 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2010 | 146 | 0.090 |
Why?
|
Antibodies, Viral | 2 | 2019 | 3213 | 0.090 |
Why?
|
Guanosine Triphosphate | 2 | 2003 | 313 | 0.080 |
Why?
|
Transplantation Conditioning | 3 | 2019 | 1635 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 7 | 2006 | 3733 | 0.080 |
Why?
|
Transplantation, Heterologous | 3 | 2021 | 2390 | 0.080 |
Why?
|
Histocompatibility | 2 | 2002 | 327 | 0.080 |
Why?
|
Genes, bcl-2 | 2 | 2001 | 119 | 0.080 |
Why?
|
Phosphatidylinositol 4,5-Diphosphate | 1 | 2009 | 122 | 0.080 |
Why?
|
Lymphoma, Follicular | 2 | 2008 | 459 | 0.080 |
Why?
|
Sirolimus | 2 | 2010 | 1541 | 0.080 |
Why?
|
Aged | 24 | 2019 | 171163 | 0.080 |
Why?
|
Kinetics | 2 | 2015 | 6273 | 0.080 |
Why?
|
Cell Membrane | 2 | 2012 | 3635 | 0.080 |
Why?
|
Cell Movement | 2 | 2011 | 5190 | 0.080 |
Why?
|
Models, Animal | 2 | 2009 | 2120 | 0.080 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2012 | 702 | 0.080 |
Why?
|
Viral Load | 1 | 2018 | 3385 | 0.080 |
Why?
|
Young Adult | 4 | 2019 | 59857 | 0.080 |
Why?
|
Oligonucleotides, Antisense | 2 | 2001 | 462 | 0.080 |
Why?
|
Blood Cells | 2 | 2008 | 307 | 0.080 |
Why?
|
Endothelial Cells | 1 | 2021 | 3586 | 0.080 |
Why?
|
ZAP-70 Protein-Tyrosine Kinase | 2 | 2000 | 69 | 0.080 |
Why?
|
Spleen | 2 | 2010 | 2294 | 0.080 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13398 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2001 | 1407 | 0.070 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 1997 | 1894 | 0.070 |
Why?
|
Cell Division | 5 | 2004 | 4466 | 0.070 |
Why?
|
Molecular Sequence Data | 9 | 2004 | 17596 | 0.070 |
Why?
|
1-Methyl-3-isobutylxanthine | 2 | 2007 | 99 | 0.070 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 691 | 0.070 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2006 | 1132 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4563 | 0.070 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2004 | 2743 | 0.070 |
Why?
|
Protein Transport | 2 | 2009 | 1938 | 0.070 |
Why?
|
Precipitin Tests | 2 | 2004 | 812 | 0.070 |
Why?
|
Tumor Cells, Cultured | 7 | 2008 | 6101 | 0.070 |
Why?
|
Cell Count | 1 | 2010 | 1823 | 0.070 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2006 | 111 | 0.070 |
Why?
|
Vaccines, DNA | 1 | 2008 | 279 | 0.070 |
Why?
|
Genes, cdc | 1 | 2006 | 113 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.060 |
Why?
|
Disease Progression | 2 | 2022 | 13614 | 0.060 |
Why?
|
Cysteine Endopeptidases | 2 | 2000 | 542 | 0.060 |
Why?
|
Glutathione Transferase | 2 | 2004 | 562 | 0.060 |
Why?
|
SKP Cullin F-Box Protein Ligases | 1 | 2006 | 173 | 0.060 |
Why?
|
Epitopes | 2 | 2007 | 2523 | 0.060 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2008 | 588 | 0.060 |
Why?
|
Interleukins | 2 | 2004 | 789 | 0.060 |
Why?
|
Cullin Proteins | 1 | 2006 | 179 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3498 | 0.060 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 1998 | 230 | 0.060 |
Why?
|
Mice, Inbred BALB C | 6 | 2006 | 6209 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2823 | 0.060 |
Why?
|
CHO Cells | 6 | 2008 | 1372 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2006 | 463 | 0.060 |
Why?
|
Oligonucleotides | 1 | 2008 | 561 | 0.060 |
Why?
|
Receptor, Notch1 | 1 | 2008 | 516 | 0.060 |
Why?
|
Profilins | 1 | 2004 | 65 | 0.060 |
Why?
|
Brain | 2 | 2024 | 27179 | 0.060 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 384 | 0.060 |
Why?
|
Lymph Nodes | 4 | 2010 | 3447 | 0.060 |
Why?
|
Vidarabine | 2 | 2019 | 343 | 0.060 |
Why?
|
Immunoblotting | 2 | 2004 | 1643 | 0.060 |
Why?
|
Glucose Transporter Type 1 | 1 | 2004 | 186 | 0.060 |
Why?
|
Cricetinae | 6 | 2008 | 2412 | 0.060 |
Why?
|
Melphalan | 2 | 2019 | 425 | 0.060 |
Why?
|
Monomeric GTP-Binding Proteins | 1 | 2005 | 197 | 0.060 |
Why?
|
DNA Primers | 2 | 2007 | 2824 | 0.060 |
Why?
|
Bone Marrow Neoplasms | 1 | 2004 | 101 | 0.060 |
Why?
|
Trans-Activators | 2 | 2005 | 2848 | 0.060 |
Why?
|
RNA Interference | 1 | 2012 | 2829 | 0.060 |
Why?
|
Interferon Type I | 1 | 1988 | 567 | 0.050 |
Why?
|
Receptors, Interleukin | 1 | 2004 | 243 | 0.050 |
Why?
|
Cambodia | 2 | 2002 | 185 | 0.050 |
Why?
|
Binding Sites | 3 | 2006 | 5999 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 3801 | 0.050 |
Why?
|
Multivariate Analysis | 2 | 2015 | 12059 | 0.050 |
Why?
|
HeLa Cells | 2 | 2006 | 3070 | 0.050 |
Why?
|
Prognosis | 7 | 2015 | 29890 | 0.050 |
Why?
|
Tuberculin Test | 2 | 2002 | 205 | 0.050 |
Why?
|
Promoter Regions, Genetic | 2 | 2006 | 5784 | 0.050 |
Why?
|
Receptors, Transferrin | 1 | 2004 | 300 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 437 | 0.050 |
Why?
|
Proline | 1 | 2004 | 452 | 0.050 |
Why?
|
Luciferases | 1 | 2004 | 712 | 0.050 |
Why?
|
Peptides | 2 | 2008 | 4331 | 0.050 |
Why?
|
Glycogen Synthase Kinases | 1 | 2002 | 40 | 0.050 |
Why?
|
Models, Biological | 5 | 2013 | 9443 | 0.050 |
Why?
|
S Phase | 2 | 2002 | 423 | 0.050 |
Why?
|
Receptor-CD3 Complex, Antigen, T-Cell | 1 | 2002 | 67 | 0.050 |
Why?
|
Fibronectins | 1 | 2006 | 720 | 0.050 |
Why?
|
Protein Interaction Mapping | 1 | 2006 | 618 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2004 | 924 | 0.050 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2002 | 92 | 0.050 |
Why?
|
Blood Proteins | 2 | 2012 | 1186 | 0.050 |
Why?
|
Depression, Chemical | 1 | 2001 | 186 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13082 | 0.050 |
Why?
|
Enzyme Inhibitors | 2 | 2004 | 3716 | 0.050 |
Why?
|
Granulocytes | 1 | 2023 | 548 | 0.050 |
Why?
|
Smad2 Protein | 1 | 2001 | 144 | 0.050 |
Why?
|
6-Aminonicotinamide | 1 | 2021 | 8 | 0.050 |
Why?
|
Bone Marrow | 4 | 1997 | 2916 | 0.050 |
Why?
|
Transplantation Tolerance | 1 | 2006 | 641 | 0.050 |
Why?
|
Transplantation, Autologous | 2 | 2013 | 2125 | 0.050 |
Why?
|
Membrane Potentials | 1 | 2004 | 1084 | 0.050 |
Why?
|
Flavonoids | 1 | 2004 | 445 | 0.050 |
Why?
|
Hypersensitivity, Delayed | 2 | 2000 | 490 | 0.050 |
Why?
|
Lectins, C-Type | 1 | 2004 | 592 | 0.050 |
Why?
|
Cyclosporine | 2 | 1994 | 777 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2016 | 3637 | 0.040 |
Why?
|
bcl-Associated Death Protein | 2 | 1998 | 102 | 0.040 |
Why?
|
Drug Synergism | 2 | 2004 | 1751 | 0.040 |
Why?
|
DNA-Binding Proteins | 3 | 2010 | 9600 | 0.040 |
Why?
|
Smad4 Protein | 1 | 2001 | 194 | 0.040 |
Why?
|
NF-kappa B | 1 | 2009 | 2492 | 0.040 |
Why?
|
Pentose Phosphate Pathway | 1 | 2021 | 125 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2002 | 489 | 0.040 |
Why?
|
Blood Platelets | 2 | 2008 | 2464 | 0.040 |
Why?
|
Antigens, Neoplasm | 3 | 2016 | 1995 | 0.040 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2002 | 330 | 0.040 |
Why?
|
DNA Fragmentation | 2 | 1997 | 238 | 0.040 |
Why?
|
CD40 Ligand | 1 | 2002 | 528 | 0.040 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2023 | 484 | 0.040 |
Why?
|
Janus Kinase 3 | 2 | 2003 | 75 | 0.040 |
Why?
|
Blood Group Incompatibility | 1 | 2001 | 134 | 0.040 |
Why?
|
Cyclin D2 | 1 | 2000 | 97 | 0.040 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2002 | 414 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2004 | 1657 | 0.040 |
Why?
|
Th1 Cells | 2 | 2002 | 1040 | 0.040 |
Why?
|
Liposomes | 1 | 2023 | 786 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 1997 | 1800 | 0.040 |
Why?
|
bcl-2-Associated X Protein | 2 | 1998 | 282 | 0.040 |
Why?
|
GTP Phosphohydrolases | 1 | 2003 | 523 | 0.040 |
Why?
|
Mitochondria | 2 | 2021 | 3669 | 0.040 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2006 | 822 | 0.040 |
Why?
|
bcl-X Protein | 2 | 1998 | 412 | 0.040 |
Why?
|
DNA Repair | 3 | 1996 | 2048 | 0.040 |
Why?
|
Listeria monocytogenes | 1 | 2021 | 244 | 0.040 |
Why?
|
Neoplasm Staging | 9 | 2004 | 11196 | 0.040 |
Why?
|
Antigens, Surface | 2 | 2001 | 1616 | 0.040 |
Why?
|
Whole-Body Irradiation | 1 | 2019 | 438 | 0.040 |
Why?
|
Acute Disease | 1 | 2009 | 7236 | 0.040 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 593 | 0.040 |
Why?
|
Ubiquitins | 1 | 2000 | 365 | 0.040 |
Why?
|
Substrate Specificity | 1 | 2002 | 1750 | 0.040 |
Why?
|
rap GTP-Binding Proteins | 1 | 1997 | 24 | 0.040 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 1997 | 34 | 0.040 |
Why?
|
Tacrolimus | 2 | 2010 | 754 | 0.040 |
Why?
|
Lymphotoxin-alpha | 2 | 1995 | 94 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2024 | 1362 | 0.040 |
Why?
|
Preleukemia | 1 | 1997 | 34 | 0.040 |
Why?
|
Immunoglobulin G | 2 | 2008 | 4555 | 0.040 |
Why?
|
Base Sequence | 2 | 2007 | 12405 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-cbl | 1 | 1997 | 120 | 0.030 |
Why?
|
Lymphatic Diseases | 2 | 2001 | 316 | 0.030 |
Why?
|
Receptor Aggregation | 2 | 1993 | 71 | 0.030 |
Why?
|
Leukemia, B-Cell | 1 | 1997 | 86 | 0.030 |
Why?
|
Fas Ligand Protein | 1 | 1997 | 214 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2001 | 1060 | 0.030 |
Why?
|
Survival Rate | 2 | 2009 | 12822 | 0.030 |
Why?
|
Protein Conformation | 1 | 2004 | 3945 | 0.030 |
Why?
|
Caspase 1 | 1 | 1997 | 227 | 0.030 |
Why?
|
Vidarabine Phosphate | 1 | 1996 | 11 | 0.030 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 1996 | 93 | 0.030 |
Why?
|
DNA | 4 | 2003 | 7193 | 0.030 |
Why?
|
Multienzyme Complexes | 1 | 2000 | 663 | 0.030 |
Why?
|
Antigens, Tumor-Associated, Carbohydrate | 1 | 1996 | 139 | 0.030 |
Why?
|
Semaphorins | 1 | 1996 | 96 | 0.030 |
Why?
|
Rats | 6 | 2023 | 23708 | 0.030 |
Why?
|
Antibodies, Bacterial | 1 | 2002 | 1473 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2000 | 561 | 0.030 |
Why?
|
Vitamin D | 1 | 2010 | 3272 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2023 | 18292 | 0.030 |
Why?
|
Dimerization | 1 | 1997 | 880 | 0.030 |
Why?
|
Transcription Factors | 2 | 2006 | 12129 | 0.030 |
Why?
|
Microglia | 1 | 2024 | 1369 | 0.030 |
Why?
|
Cricetulus | 2 | 2008 | 806 | 0.030 |
Why?
|
Cloning, Molecular | 3 | 1998 | 4163 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2024 | 1886 | 0.030 |
Why?
|
Adjuvants, Immunologic | 1 | 2000 | 993 | 0.030 |
Why?
|
Clinical Trials as Topic | 2 | 2008 | 8037 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2013 | 5189 | 0.030 |
Why?
|
Burkitt Lymphoma | 1 | 1997 | 338 | 0.030 |
Why?
|
Paraproteins | 1 | 1994 | 38 | 0.030 |
Why?
|
Leukocytes | 3 | 1994 | 2027 | 0.030 |
Why?
|
Mitogens | 2 | 2010 | 228 | 0.030 |
Why?
|
Green Fluorescent Proteins | 2 | 2012 | 2062 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2022 | 2036 | 0.030 |
Why?
|
Bleomycin | 3 | 2004 | 491 | 0.030 |
Why?
|
Monocytes | 1 | 2023 | 2591 | 0.030 |
Why?
|
Receptors, Cytokine | 1 | 1995 | 257 | 0.030 |
Why?
|
Vinblastine | 3 | 2004 | 483 | 0.030 |
Why?
|
Interleukin-1 | 1 | 1997 | 1242 | 0.030 |
Why?
|
Genetic Vectors | 1 | 2003 | 3400 | 0.030 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 1997 | 571 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 5 | 2013 | 11858 | 0.030 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1993 | 141 | 0.030 |
Why?
|
Escherichia coli | 1 | 2006 | 4210 | 0.030 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2000 | 1314 | 0.030 |
Why?
|
Calcineurin | 1 | 1994 | 233 | 0.030 |
Why?
|
Graft Rejection | 1 | 2006 | 4503 | 0.030 |
Why?
|
Calmodulin-Binding Proteins | 1 | 1994 | 237 | 0.030 |
Why?
|
O(6)-Methylguanine-DNA Methyltransferase | 4 | 1996 | 82 | 0.030 |
Why?
|
Phosphoprotein Phosphatases | 1 | 1994 | 327 | 0.030 |
Why?
|
Epirubicin | 2 | 2004 | 82 | 0.030 |
Why?
|
Mice, SCID | 2 | 2011 | 2626 | 0.030 |
Why?
|
Electroporation | 1 | 1993 | 238 | 0.030 |
Why?
|
Transplantation Immunology | 1 | 1994 | 540 | 0.030 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2001 | 1076 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2013 | 364 | 0.020 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 1996 | 645 | 0.020 |
Why?
|
Macrophage-1 Antigen | 1 | 2013 | 283 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2000 | 1961 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 1009 | 0.020 |
Why?
|
Leukemia, Hairy Cell | 1 | 1991 | 82 | 0.020 |
Why?
|
Immune System | 1 | 2016 | 799 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2002 | 1909 | 0.020 |
Why?
|
Vincristine | 3 | 2004 | 1037 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-vav | 1 | 2011 | 91 | 0.020 |
Why?
|
Reference Values | 2 | 1997 | 4909 | 0.020 |
Why?
|
Major Histocompatibility Complex | 1 | 1993 | 879 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2004 | 15401 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2536 | 0.020 |
Why?
|
Thrombocytosis | 1 | 1991 | 88 | 0.020 |
Why?
|
Mechlorethamine | 2 | 2004 | 129 | 0.020 |
Why?
|
Methyltransferases | 4 | 1996 | 372 | 0.020 |
Why?
|
Genes, T-Cell Receptor beta | 1 | 2010 | 70 | 0.020 |
Why?
|
Splenectomy | 1 | 1991 | 389 | 0.020 |
Why?
|
Complement System Proteins | 1 | 2013 | 716 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2011 | 234 | 0.020 |
Why?
|
Thrombocythemia, Essential | 1 | 1991 | 114 | 0.020 |
Why?
|
Placenta | 1 | 2018 | 1726 | 0.020 |
Why?
|
Cell Fusion | 1 | 2010 | 294 | 0.020 |
Why?
|
Tuberculosis | 1 | 2002 | 2009 | 0.020 |
Why?
|
Time Factors | 3 | 2004 | 40097 | 0.020 |
Why?
|
Antilymphocyte Serum | 1 | 2010 | 492 | 0.020 |
Why?
|
Alternative Splicing | 1 | 1993 | 1103 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1601 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2011 | 465 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2012 | 1944 | 0.020 |
Why?
|
Leukocyte Count | 2 | 1991 | 1605 | 0.020 |
Why?
|
Receptor, PAR-1 | 1 | 2008 | 109 | 0.020 |
Why?
|
Leukemia | 2 | 2010 | 1522 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1993 | 1739 | 0.020 |
Why?
|
Lymphoma, B-Cell | 1 | 1994 | 943 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2013 | 1555 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2011 | 2008 | 0.020 |
Why?
|
Cell Polarity | 1 | 2010 | 636 | 0.020 |
Why?
|
Influenza Vaccines | 1 | 1994 | 780 | 0.020 |
Why?
|
Phytohemagglutinins | 2 | 1996 | 164 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2010 | 1346 | 0.020 |
Why?
|
Species Specificity | 3 | 1996 | 2406 | 0.020 |
Why?
|
NFATC Transcription Factors | 1 | 2008 | 391 | 0.020 |
Why?
|
Fluorescence | 1 | 2008 | 751 | 0.020 |
Why?
|
Autoantibodies | 1 | 1994 | 2114 | 0.020 |
Why?
|
Prednisone | 2 | 2004 | 1566 | 0.020 |
Why?
|
Radiotherapy Dosage | 2 | 2004 | 2863 | 0.020 |
Why?
|
Carcinoma | 1 | 1996 | 2311 | 0.020 |
Why?
|
Cell Transplantation | 1 | 2007 | 473 | 0.020 |
Why?
|
Interleukin Receptor Common gamma Subunit | 1 | 2004 | 89 | 0.010 |
Why?
|
Interleukin-9 | 1 | 2004 | 62 | 0.010 |
Why?
|
Immunoglobulins | 2 | 2000 | 853 | 0.010 |
Why?
|
Gene Silencing | 1 | 2011 | 1504 | 0.010 |
Why?
|
Antibody Specificity | 2 | 1998 | 1061 | 0.010 |
Why?
|
Vaccinia | 1 | 2004 | 71 | 0.010 |
Why?
|
Focal Adhesions | 1 | 2004 | 113 | 0.010 |
Why?
|
Megakaryocytes | 1 | 2008 | 557 | 0.010 |
Why?
|
Autocrine Communication | 1 | 2004 | 167 | 0.010 |
Why?
|
Interleukin-15 | 1 | 2004 | 186 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1991 | 4851 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 2001 | 1527 | 0.010 |
Why?
|
Combined Modality Therapy | 3 | 2004 | 8522 | 0.010 |
Why?
|
Random Allocation | 1 | 1988 | 2394 | 0.010 |
Why?
|
Isoantibodies | 1 | 2007 | 681 | 0.010 |
Why?
|
Nuclear Proteins | 1 | 1997 | 5782 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3599 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2018 | 9525 | 0.010 |
Why?
|
Tuberculin | 1 | 2002 | 63 | 0.010 |
Why?
|
Doxorubicin | 2 | 2004 | 2226 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2004 | 614 | 0.010 |
Why?
|
Chlorambucil | 1 | 2001 | 42 | 0.010 |
Why?
|
Drug Monitoring | 1 | 2008 | 960 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2006 | 1202 | 0.010 |
Why?
|
Hepatomegaly | 1 | 2001 | 83 | 0.010 |
Why?
|
Karyotyping | 1 | 2003 | 1175 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39228 | 0.010 |
Why?
|
Lentivirus | 1 | 2004 | 518 | 0.010 |
Why?
|
Mumps | 1 | 2002 | 71 | 0.010 |
Why?
|
Salvage Therapy | 1 | 2008 | 1272 | 0.010 |
Why?
|
Blood Viscosity | 1 | 2001 | 125 | 0.010 |
Why?
|
Survival Analysis | 2 | 2007 | 10086 | 0.010 |
Why?
|
Splenomegaly | 1 | 2001 | 191 | 0.010 |
Why?
|
Cardiac Output, Low | 1 | 2001 | 192 | 0.010 |
Why?
|
Fibroblasts | 2 | 2004 | 4161 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1998 | 20133 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2011 | 4882 | 0.010 |
Why?
|
Neutrophils | 1 | 2013 | 3769 | 0.010 |
Why?
|
Skin Tests | 1 | 2002 | 630 | 0.010 |
Why?
|
Translocation, Genetic | 2 | 1998 | 1393 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2004 | 1716 | 0.010 |
Why?
|
Graft Survival | 1 | 2010 | 3904 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2000 | 1140 | 0.010 |
Why?
|
Mice, Inbred NOD | 1 | 2003 | 1837 | 0.010 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 2057 | 0.010 |
Why?
|
Rabbits | 2 | 1996 | 4729 | 0.010 |
Why?
|
Mutation | 1 | 2023 | 30192 | 0.010 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 1998 | 20 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1998 | 340 | 0.010 |
Why?
|
Antibodies, Blocking | 1 | 1998 | 249 | 0.010 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2001 | 678 | 0.010 |
Why?
|
Chromosomes, Human, Pair 18 | 1 | 1998 | 247 | 0.010 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 1998 | 285 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2411 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 1999 | 791 | 0.010 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 2206 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 30230 | 0.010 |
Why?
|
Transplantation Chimera | 1 | 1999 | 609 | 0.010 |
Why?
|
Adolescent | 6 | 2004 | 88811 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1998 | 287 | 0.010 |
Why?
|
Cell Aggregation | 1 | 1996 | 238 | 0.010 |
Why?
|
Neoplasms, Second Primary | 1 | 2004 | 1056 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2004 | 6202 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2004 | 3419 | 0.010 |
Why?
|
Receptors, IgE | 1 | 1996 | 374 | 0.010 |
Why?
|
Oligoclonal Bands | 1 | 1994 | 17 | 0.010 |
Why?
|
DNA Damage | 2 | 1996 | 2462 | 0.010 |
Why?
|
Multigene Family | 1 | 1998 | 1081 | 0.010 |
Why?
|
Fatigue | 1 | 2001 | 1553 | 0.010 |
Why?
|
Keratinocytes | 1 | 1998 | 861 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1995 | 300 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1993 | 416 | 0.010 |
Why?
|
Melanoma, Experimental | 1 | 1996 | 555 | 0.010 |
Why?
|
Phenotype | 2 | 2003 | 16714 | 0.010 |
Why?
|
Bone Marrow Examination | 1 | 1993 | 155 | 0.010 |
Why?
|
Cross Reactions | 1 | 1995 | 824 | 0.010 |
Why?
|
Risk | 1 | 2004 | 9599 | 0.010 |
Why?
|
Organ Specificity | 1 | 1996 | 1964 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6542 | 0.010 |
Why?
|
Biopsy | 2 | 1994 | 6766 | 0.010 |
Why?
|
Rural Population | 1 | 2002 | 2318 | 0.010 |
Why?
|
Aged, 80 and over | 3 | 2004 | 59496 | 0.010 |
Why?
|
Immunoassay | 1 | 1994 | 742 | 0.010 |
Why?
|
Hypersensitivity, Immediate | 1 | 1994 | 346 | 0.010 |
Why?
|
Immunoglobulin A | 1 | 1994 | 992 | 0.010 |
Why?
|
DNA, Complementary | 1 | 1993 | 1984 | 0.010 |
Why?
|
Lymphoma | 1 | 1999 | 1896 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1991 | 2077 | 0.010 |
Why?
|
Hemorrhage | 1 | 2001 | 3466 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1993 | 10727 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2004 | 14643 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1993 | 2172 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 1996 | 21069 | 0.010 |
Why?
|
Antibody Formation | 1 | 1994 | 1392 | 0.000 |
Why?
|
Epithelium | 1 | 1993 | 1603 | 0.000 |
Why?
|
Injections, Intravenous | 1 | 1991 | 1376 | 0.000 |
Why?
|
Cerebral Cortex | 1 | 2004 | 5765 | 0.000 |
Why?
|
Platelet Count | 1 | 1991 | 784 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1996 | 988 | 0.000 |
Why?
|
Physical Examination | 1 | 1993 | 1263 | 0.000 |
Why?
|
Severity of Illness Index | 1 | 2004 | 15878 | 0.000 |
Why?
|
Incidence | 1 | 2004 | 21513 | 0.000 |
Why?
|
Neurons | 1 | 2004 | 9527 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1996 | 8107 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1993 | 6058 | 0.000 |
Why?
|
Child | 2 | 2004 | 80568 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1994 | 11030 | 0.000 |
Why?
|
Cohort Studies | 1 | 2002 | 41680 | 0.000 |
Why?
|
Diagnosis, Differential | 1 | 1993 | 12973 | 0.000 |
Why?
|
Pilot Projects | 1 | 1991 | 8724 | 0.000 |
Why?
|
Infant | 1 | 1999 | 36426 | 0.000 |
Why?
|
Child, Preschool | 1 | 1999 | 42510 | 0.000 |
Why?
|
Liver | 1 | 1990 | 7559 | 0.000 |
Why?
|
Retrospective Studies | 1 | 2001 | 81537 | 0.000 |
Why?
|